Immuno-related adverse events from check-point inhibitors during immune-therapy for cancer. Imaging findings
European Journal of Cancer(2018)
Abstract
Poster: ECR 2018 / C-2079 / Immuno-related adverse events (irAE) from check-Point inhibitors during immunotherapy for cancer. Imaging Findings. by: F. Sandomenico1, S. Pizza2, G. De Rosa1, O. Catalano3, E. simeone1, L. festino1, A. M. grimaldi1, P. Ascierto3, A. Petrillo3; 1Napoli/IT, 2Napoli (NA)/IT, 3Naples/IT
MoreTranslated text
Key words
inhibitors,cancer,adverse events,immuno-related,check-point,immune-therapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined